Search research articles
Contact Us
Filters
Showing results (431-440 of 440) with videos related to
Page
of 44
Sort By:
You have reached the last page of results.
This site can display upto 440 results.
Science (New York, N.Y.)
|
July 6, 2013
Bringing ecosystem services into economic decision-making: land use in the United Kingdom
Ian J Bateman, Amii R Harwood, Georgina M Mace, et al.
BMC Genomics
|
January 5, 2018
No association between ACTN3 R577X and ACE I/D polymorphisms and endurance running times in 698 Caucasian athletes
Ioannis D Papadimitriou, Sarah J Lockey, Sarah Voisin, et al.
Journal of Medicinal Chemistry
|
February 16, 2007
Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524)
Claudio F Sturino, Gary O'Neill, Nicolas Lachance, et al.
Journal of Medicinal Chemistry
|
August 13, 2021
Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2
Tom D Heightman, Valerio Berdini, Luke Bevan, et al.
Journal of Medicinal Chemistry
|
May 19, 2018
Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2
Tom D Heightman, Valerio Berdini, Hannah Braithwaite, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2024
How to make land use policy decisions: Integrating science and economics to deliver connected climate, biodiversity, and food objectives
Ian J Bateman, Amy Binner, Ethan T Addicott, et al.
Journal of Medicinal Chemistry
|
May 8, 2025
Correction to "Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)"
James E H Day, Valerio Berdini, Joan Castro, et al.
Journal of Medicinal Chemistry
|
March 11, 2024
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)
James E H Day, Valerio Berdini, Joan Castro, et al.
Physical Review Letters
|
August 26, 2022
Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment
H Abu-Shawareb, R Acree, P Adams, et al.
Physical Review Letters
|
February 23, 2024
Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment
H Abu-Shawareb, R Acree, P Adams, et al.
Page
of 44
Search research articles
Search
Showing results (431-440 of 440) with videos related to
Sort By:
Page
of 44
You have reached the last page of results.
This site can display upto 440 results.
Science (New York, N.Y.)
|
July 6, 2013
Bringing ecosystem services into economic decision-making: land use in the United Kingdom
Ian J Bateman, Amii R Harwood, Georgina M Mace, et al.
BMC Genomics
|
January 5, 2018
No association between ACTN3 R577X and ACE I/D polymorphisms and endurance running times in 698 Caucasian athletes
Ioannis D Papadimitriou, Sarah J Lockey, Sarah Voisin, et al.
Journal of Medicinal Chemistry
|
February 16, 2007
Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524)
Claudio F Sturino, Gary O'Neill, Nicolas Lachance, et al.
Journal of Medicinal Chemistry
|
August 13, 2021
Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2
Tom D Heightman, Valerio Berdini, Luke Bevan, et al.
Journal of Medicinal Chemistry
|
May 19, 2018
Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2
Tom D Heightman, Valerio Berdini, Hannah Braithwaite, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2024
How to make land use policy decisions: Integrating science and economics to deliver connected climate, biodiversity, and food objectives
Ian J Bateman, Amy Binner, Ethan T Addicott, et al.
Journal of Medicinal Chemistry
|
May 8, 2025
Correction to "Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)"
James E H Day, Valerio Berdini, Joan Castro, et al.
Journal of Medicinal Chemistry
|
March 11, 2024
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)
James E H Day, Valerio Berdini, Joan Castro, et al.
Physical Review Letters
|
August 26, 2022
Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment
H Abu-Shawareb, R Acree, P Adams, et al.
Physical Review Letters
|
February 23, 2024
Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment
H Abu-Shawareb, R Acree, P Adams, et al.
Page
of 44